Canagliflozin and Myocardial Micro-perfusion

Conditions:   Type 2 Diabetes;   Cardiovascular Diseases;   Cardiac Perfusion Defect Intervention:   Drug: Canagliflozin 100mg or Sitagliptin 100mg Sponsor:   Shanghai Zhongshan Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials